 | Compass Therapeutics, Inc. | |||
| NCM : CMPX || Location: United States | ||||
$1.47-0.01 (-0.68%) |
0.4 M | 1.33 - 1.48 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.617 M |
| March 28, 2024 | 1.624 M |
| March 15, 2024 | 1.883 M |
| Feb. 29, 2024 | 1.842 M |
| Feb. 15, 2024 | 1.972 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.10 | -0.11 | -14.58% |
| 09/30/2023 | -0.11 | -0.08 | 26.81% |
| 06/30/2023 | -0.08 | -0.09 | -8.30% |
| 03/31/2023 | -0.11 | -0.06 | 45.80% |
| 12/31/2022 | -0.11 | -0.10 | 12.89% |
CMPX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 137.589M | Shares Float | 102.853M |
| Short Float | 1.617M | Market Cap | 203.63M |
| Institution ownership | 62.88% | Insider ownership | 13.437% |
| Earnings Date | 05/06/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.33 | Forward EPS | -0.50 |